Academy Courses
$WGRXJun 26, 2026, 12:30 PMAI processed

WGRX proposes rename to DataMeds AI (proposed ticker MEDS), rebrands pharmacy unit and targets Q3 2026 closing

AI Summary

Wellgistics Health (NASDAQ: WGRX) said its board selected DataMeds AI, Inc. as the proposed new corporate name (proposed ticker MEDS) and filed a preliminary proxy with the SEC seeking shareholder approval; it also will rebrand its Pharmacy division as Corexa Health while pursuing a proposed transaction with DataVault AI, Scilex, EOS and HealthBridge aimed at vertically integrating telemedicine, pharmacy, labs and wearables, targeted for completion in Q3 2026 subject to customary closing conditions. The company reports 2,647,198 common shares outstanding with ~1,333,930 shares locked up for at least 90 days, 919,465 shares deposited at DTCC available for trading, 80,826 cash warrants outstanding at a $35 strike, and no convertible debt or preferred equity currently eligible to convert to free-trading common shares.

Positives

  • Preliminary proxy filed with the SEC requesting shareholder approval for the name change (shows progression toward rebrand)
  • Majority of outstanding shares (~1.33M of 2.65M) are under a 90-day lock-up, reducing immediate sell pressure
  • No debt or preferred equity currently eligible to convert into free-trading common shares

Negatives

  • Proposed name change and multi-party transaction remain subject to shareholder approval and customary closing conditions (may not complete)
  • There are 80,826 cash warrants outstanding (fixed $35 exercise) that represent potential dilution if exercised
  • Small total share count (~2.65M) and limited DTCC-deposited float (919,465) imply thin liquidity and potential price volatility